share_log

国药控股(01099.HK):前三季度归母净利润52.79亿元 同比下降13.4%

Sinopharm (01099.HK): The net income attributable to the parent company in the first three quarters was 5.279 billion yuan, a year-on-year decrease of 13.4%.

Gelonghui Finance ·  Oct 28, 2024 08:26

Gelonghui, October 28 | Sinopharm Holdings (01099.HK) announced that for the nine months ended September 30, 2024, total revenue reached RMB 442.423 billion, which was basically flat% year on year. Net profit attributable to owners of the parent company was RMB 5.279 billion, down 13.4% year on year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment